• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAN
Click for more information
0.00% 4.6¢

CANN GROUP LIMITED - Announcements

Market Cap $17.80M  ! watchlist Created with Sketch. Add to my watchlist

Cann Group Limited is an Australia-based company that is focused on developing,... Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation, and good manufacturing practices (GMP) manufacturing facilities are in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
CAN Investor PresentationPRICE SENSITIVE21/03/19
CAN Revised expansion plans and offtake agreement executedPRICE SENSITIVE19/03/19
CAN Appendix 4DPRICE SENSITIVE18/02/19
CAN Appendix 4C - quarterlyPRICE SENSITIVE30/01/19
CAN Chairman & CEO Addresses to ShareholdersPRICE SENSITIVE14/11/18
CAN Cann Market Update PresentationPRICE SENSITIVE30/10/18
CAN Appendix 4C - quarterlyPRICE SENSITIVE30/10/18
CAN Cann secures Victorian Govt tender to supply cannabis resinPRICE SENSITIVE29/10/18
CAN Cann signs R&D Agreement with CSIROPRICE SENSITIVE25/10/18
CAN Annual Report PresentationPRICE SENSITIVE23/08/18
CAN Annual Report to shareholders and Appendix 4EPRICE SENSITIVE23/08/18
CAN First Aust patients prescribed with Aurora medical cannabisPRICE SENSITIVE15/08/18
CAN IDT: and Cann Group Medicinal Cannabis PartnershipPRICE SENSITIVE07/08/18
CAN Cann welcomes first Research Hub for Medicinal AgriculturePRICE SENSITIVE02/08/18
CAN Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
CAN Site secured for Aust largest medicinal cannabis operationPRICE SENSITIVE27/06/18 download Created with Sketch. 151.04KB
CAN R&D Expansion at La Trobe UniversityPRICE SENSITIVE06/06/18 download Created with Sketch. 148.86KB
CAN Response to ASX Aware QueryPRICE SENSITIVE03/05/18
CAN Takeover speculation in the mediaPRICE SENSITIVE30/04/18
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/04/18
CAN Leading Global Consultancy appointed for Phase 3 facilityPRICE SENSITIVE19/04/18
CAN S&P DJ Indices Announces March Quarterly RebalancePRICE SENSITIVE09/03/18
CAN Receipt of Import Permits for Genetics and Cannabis OilPRICE SENSITIVE06/03/18
CAN Cann executes MOU with Under The Tree BiopharmaceuticalsPRICE SENSITIVE23/02/18
CAN Granting of New Research and Medicinal Cannabis LicencesPRICE SENSITIVE19/02/18
CAN Appendix 4D to Half Yearly Report and AccountsPRICE SENSITIVE06/02/18
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/01/18
CAN Federal Government Announcement on Medicinal Cannabis ExportPRICE SENSITIVE04/01/18
CAN Cann Group Successfully Completes PlacementPRICE SENSITIVE04/12/17
CAN Fully underwritten $60 million capital raisePRICE SENSITIVE30/11/17
CAN Trading HaltPRICE SENSITIVE29/11/17
CAN Cann Group Granted Cannabis Import / Export LicencePRICE SENSITIVE27/10/17
CAN Licence Variations GrantedPRICE SENSITIVE25/10/17
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE16/10/17
CAN Cann Group Joins Medicinal Cannabis Information PortalPRICE SENSITIVE01/09/17
CAN Appendix 4E and 2017 Annual ReportPRICE SENSITIVE29/08/17
CAN Cann Group Completes First Harvest ProductionPRICE SENSITIVE28/08/17
CAN Cann Group - CannaKorp Agreement AnnouncementPRICE SENSITIVE25/08/17
CAN Price Query ResponsePRICE SENSITIVE18/08/17
CAN Quarterly Activities Report and Quarterly Appendix 4CPRICE SENSITIVE28/07/17
CAN Aurora and Cann Group Execute Technical Services AgreementPRICE SENSITIVE19/07/17
CAN Cann secures permits to start cultivationPRICE SENSITIVE30/05/17
CAN ASX Market Release - Admission to the Official ListPRICE SENSITIVE03/05/17
CAN Investor Presentation
21/03/19PRICE SENSITIVE
CAN Revised expansion plans and offtake agreement executed
19/03/19PRICE SENSITIVE
CAN Appendix 4D
18/02/19PRICE SENSITIVE
CAN Appendix 4C - quarterly
30/01/19PRICE SENSITIVE
CAN Chairman & CEO Addresses to Shareholders
14/11/18PRICE SENSITIVE
CAN Cann Market Update Presentation
30/10/18PRICE SENSITIVE
CAN Appendix 4C - quarterly
30/10/18PRICE SENSITIVE
CAN Cann secures Victorian Govt tender to supply cannabis resin
29/10/18PRICE SENSITIVE
CAN Cann signs R&D Agreement with CSIRO
25/10/18PRICE SENSITIVE
CAN Annual Report Presentation
23/08/18PRICE SENSITIVE
CAN Annual Report to shareholders and Appendix 4E
23/08/18PRICE SENSITIVE
CAN First Aust patients prescribed with Aurora medical cannabis
15/08/18PRICE SENSITIVE
CAN IDT: and Cann Group Medicinal Cannabis Partnership
07/08/18PRICE SENSITIVE
CAN Cann welcomes first Research Hub for Medicinal Agriculture
02/08/18PRICE SENSITIVE
CAN Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
CAN Site secured for Aust largest medicinal cannabis operation
27/06/18PRICE SENSITIVE download Created with Sketch. 151.04KB
CAN R&D Expansion at La Trobe University
06/06/18PRICE SENSITIVE download Created with Sketch. 148.86KB
CAN Response to ASX Aware Query
03/05/18PRICE SENSITIVE
CAN Takeover speculation in the media
30/04/18PRICE SENSITIVE
CAN Quarterly Activities Report and Appendix 4C
27/04/18PRICE SENSITIVE
CAN Leading Global Consultancy appointed for Phase 3 facility
19/04/18PRICE SENSITIVE
CAN S&P DJ Indices Announces March Quarterly Rebalance
09/03/18PRICE SENSITIVE
CAN Receipt of Import Permits for Genetics and Cannabis Oil
06/03/18PRICE SENSITIVE
CAN Cann executes MOU with Under The Tree Biopharmaceuticals
23/02/18PRICE SENSITIVE
CAN Granting of New Research and Medicinal Cannabis Licences
19/02/18PRICE SENSITIVE
CAN Appendix 4D to Half Yearly Report and Accounts
06/02/18PRICE SENSITIVE
CAN Quarterly Activities Report and Appendix 4C
31/01/18PRICE SENSITIVE
CAN Federal Government Announcement on Medicinal Cannabis Export
04/01/18PRICE SENSITIVE
CAN Cann Group Successfully Completes Placement
04/12/17PRICE SENSITIVE
CAN Fully underwritten $60 million capital raise
30/11/17PRICE SENSITIVE
CAN Trading Halt
29/11/17PRICE SENSITIVE
CAN Cann Group Granted Cannabis Import / Export Licence
27/10/17PRICE SENSITIVE
CAN Licence Variations Granted
25/10/17PRICE SENSITIVE
CAN Quarterly Activities Report and Appendix 4C
16/10/17PRICE SENSITIVE
CAN Cann Group Joins Medicinal Cannabis Information Portal
01/09/17PRICE SENSITIVE
CAN Appendix 4E and 2017 Annual Report
29/08/17PRICE SENSITIVE
CAN Cann Group Completes First Harvest Production
28/08/17PRICE SENSITIVE
CAN Cann Group - CannaKorp Agreement Announcement
25/08/17PRICE SENSITIVE
CAN Price Query Response
18/08/17PRICE SENSITIVE
CAN Quarterly Activities Report and Quarterly Appendix 4C
28/07/17PRICE SENSITIVE
CAN Aurora and Cann Group Execute Technical Services Agreement
19/07/17PRICE SENSITIVE
CAN Cann secures permits to start cultivation
30/05/17PRICE SENSITIVE
CAN ASX Market Release - Admission to the Official List
03/05/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
4.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.80M
Open High Low Value Volume
4.8¢ 4.8¢ 4.6¢ $11.93K 252.9K

Buyers (Bids)

No. Vol. Price($)
2 4849 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 198859 5
View Market Depth
Last trade - 15.32pm 22/11/2024 (20 minute delay) ?
Last
4.6¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
4.6¢ 4.7¢ 4.6¢ 129173
Last updated 15.52pm 22/11/2024 ?
CAN (ASX) Chart

Top Stories

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.